Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:50 PM
Ignite Modification Date:
2025-12-24 @ 5:50 PM
NCT ID:
NCT04933968
Eligibility Criteria:
Inclusion Criteria:
* Undergone hematopoietic cell transplantation (HCT) ≥21 days or solid organ transplantation (SOT) ≥28 days prior to study treatment administration
* Detection of at least 1 target virus of interest (ie, RSV, influenza, hMPV, and/or PIV)
* Diagnosis of Upper or mild Lower Respiratory Tract Infection
Exclusion Criteria:
* Ongoing therapy with high-dose systemic corticosteroids (ie, prednisone equivalent dose \>0.5 mg/kg/day)
* Infection by novel coronavirus disease 2019 (COVID-19)
* For HCT patients, evidence of Grade \>2 GVHD; and for SOT patients, any history or evidence of GVHD
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
17 Years
Maximum Age:
75 Years
Study:
NCT04933968
Study Brief:
Protocol Section:
NCT04933968